KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $10.0 million.

  • Astrana Health's Cash from Operations fell 7070.13% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.5 million, marking a year-over-year increase of 2921.79%. This contributed to the annual value of $52.2 million for FY2024, which is 2349.36% down from last year.
  • Astrana Health's Cash from Operations amounted to $10.0 million in Q3 2025, which was down 7070.13% from $90.9 million recorded in Q2 2025.
  • In the past 5 years, Astrana Health's Cash from Operations ranged from a high of $90.9 million in Q2 2025 and a low of -$35.9 million during Q3 2022
  • Moreover, its 5-year median value for Cash from Operations was $16.6 million (2025), whereas its average is $20.5 million.
  • As far as peak fluctuations go, Astrana Health's Cash from Operations plummeted by 36866.59% in 2021, and later soared by 79679.25% in 2022.
  • Over the past 5 years, Astrana Health's Cash from Operations (Quarter) stood at -$12.2 million in 2021, then soared by 796.79% to $84.9 million in 2022, then plummeted by 77.28% to $19.3 million in 2023, then tumbled by 156.73% to -$10.9 million in 2024, then surged by 190.94% to $10.0 million in 2025.
  • Its Cash from Operations stands at $10.0 million for Q3 2025, versus $90.9 million for Q2 2025 and $16.6 million for Q1 2025.